| |
|
|
|
Viking Thera  
|
|
5.57 -0.16 (-0.03%) |
10-20 16:00 |
|
Open: |
5.76 |
Pre close: |
5.73 |
Target:
|
7.36
|
|
High: |
5.771 |
Low: |
5.56 |
Resistance:
|
6.30
6.84
|
|
Volume: |
1,142,145 |
Market Cap: |
405M |
Support:
|
5.43
4.52
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.80
 |
MACD |
MACD(12,26):
|
-0.18 |
|
MA(20): |
5.92 |
Signal(12,26,9): |
-0.18  |
|
MA(100): |
6.87 |
Stochastic Oscillator |
%K(14,3):
|
37.67 |
|
MA(250): |
6.71 |
%D(3): |
45.09 |
|
Average Volume(K) |
3-Month: |
124377
|
52-Week |
High:
|
8.87 |
|
10-Days: |
88751 |
Low: |
3.26 |
|
RSI |
RSI(14):
|
37.14 |
Change(%): |
-14.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.450 |
Return on Equity (ttm) |
-11.8 |
Shares Out. (M) |
72.76 |
|
EPS Est. Current Year |
-0.830 |
Return on Assets (ttm) |
-8.4 |
Shares Float (M) |
56.61 |
|
EPS Est. Next Year |
-0.800 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.98 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
56.67 |
|
Forward EPS |
-0.360 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
9340 |
|
Book Value (p.s.) |
3.600 |
EBITDA (p.s.) |
0.000 |
P/E |
-12.56 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.57 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-26.11 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-21.46 |
P/CF |
-15.74 |
|
|
|
|
|
|
